The Iliac/SFA/Popliteal Center

Filter Your Results




Covered Stents for the Treatment of SFA Occlusive Disease

Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

October 2008—A case-based discussion of stent graft use in this challenging anatomy.

Drug-Coated Balloons

Gunnar Tepe, MD, and Ulrich Speck, Phd

October 2008—Paclitaxel-coated balloons show promise as a treatment option for intravascular interventions.

Practical Uses of Cryoplasty

Pranab Das, MD; Santosh K. Koshy, MD; Robert S. Dieter, MD, RVT; and Aravinda Nanjundappa, MD, RVT

October 2008—A look at some of the effective applications of this nonsurgical treatment option.

Lessons Learned in RESILIENT

October 2008—Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.

The Zilver PTX Global Registry and RCT

October 2008—Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.


October 2008—Krishna Rocha-Singh, MD, FACC, FSCAI, discusses the current status of the DURABILITY II trial, a challenging landmark study of patency and fracture resistance of stenting in the superficial femoral and popliteal arteries.

Dynamic Forces in the SFA and Popliteal Artery During Knee Flexion

Frederik H.W. Jonker, MS; Felix J.V. Schlösser, MD; Frans L. Moll, MD, PhD; and Bart E. Muhs, MD, PhD

May 2008—Consequences of stress to consider for stent durability and design.

Tackling Popliteal Artery Lesions

Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

May 2008—Today's devices enable lesion-specific care tailored to each patient.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.